Prestige Biopharma and Charles River Laboratories have signed a MoU establishing a mutual client referral arrangement to accelerate biosimilar development.
Prestige Biopharma and Charles River Laboratories have signed a MoU establishing a mutual client referral arrangement to accelerate biosimilar development.